Astellas Pharma, Inc. (ALPMY)
Astellas Pharma Market Cap : 30.21B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 30.21B |
| November 12, 2026 | 29.60B |
| November 11, 2026 | 29.55B |
| November 10, 2026 | 29.43B |
| November 09, 2026 | 29.60B |
| November 06, 2026 | 28.37B |
| November 05, 2026 | 29.39B |
| November 04, 2026 | 28.73B |
| November 03, 2026 | 28.91B |
| November 02, 2026 | 29.07B |
| October 30, 2026 | 28.98B |
| October 29, 2026 | 28.69B |
| October 28, 2026 | 28.47B |
| October 27, 2026 | 28.58B |
| October 26, 2026 | 29.17B |
| October 23, 2026 | 28.60B |
| October 22, 2026 | 28.28B |
| October 21, 2026 | 28.11B |
| October 20, 2026 | 27.76B |
| October 19, 2026 | 27.15B |
| October 16, 2026 | 27.13B |
| October 15, 2026 | 26.73B |
| October 14, 2026 | 25.73B |
| October 13, 2026 | 25.80B |
| October 12, 2026 | 25.73B |
| Date | Value |
|---|---|
| October 09, 2026 | 25.73B |
| October 08, 2026 | 25.46B |
| October 07, 2026 | 25.53B |
| October 06, 2026 | 25.37B |
| October 05, 2026 | 25.48B |
| October 02, 2026 | 25.68B |
| October 01, 2026 | 25.89B |
| September 30, 2026 | 25.94B |
| September 29, 2026 | 26.54B |
| September 28, 2026 | 26.81B |
| September 25, 2026 | 27.29B |
| September 24, 2026 | 26.68B |
| September 23, 2026 | 27.00B |
| September 22, 2026 | 27.52B |
| September 21, 2026 | 27.27B |
| September 18, 2026 | 27.22B |
| September 17, 2026 | 27.24B |
| September 16, 2026 | 26.48B |
| September 15, 2026 | 26.64B |
| September 14, 2026 | 26.63B |
| September 11, 2026 | 26.11B |
| September 10, 2026 | 25.50B |
| September 09, 2026 | 25.87B |
| September 08, 2026 | 26.34B |
| September 04, 2026 | 26.98B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 68.47B |
| Daiichi Sankyo Co., Ltd. | 32.74B |
| Eisai Co., Ltd. | 9.157B |
| Chugai Pharmaceutical Co., Ltd. | 74.07B |
| Santen Pharmaceutical Co., Ltd. | 4.077B |
Market Cap Related Metrics
| PE Ratio | 12.38 |
| PS Ratio | 2.004 |
| PEG Ratio | 0.0671 |
| Price to Book Value | 2.395 |
| Price to Free Cash Flow | 10.84 |
| Price | 16.84 |
| Earnings Yield | 8.08% |
| PEGY Ratio | 0.0671 |
| Operating PE Ratio | 8.589 |
| Normalized PE Ratio | 12.38 |